Sponsor or institution

Clinical trials and research at Arrowhead Pharmaceuticals

• 7Clinical trials
• 32Countries

Newest trials

All recruiting trials (7)

• First-in-human test of ARO-033 in adults

  This study tests whether ARO-033 is safe and tolerable, and how it behaves in the body, in healthy adults and in adults with age-related macular degeneration.

  Recruiting Phase 1 Arrowhead Pharmaceuticals · Auckland · NCT07662096

• Zodasiran for teens with homozygous familial hypercholesterolemia

  This study tests whether subcutaneous Zodasiran can help adolescents with HoFH who have very high LDL-C despite lipid-lowering therapy.

  Recruiting at 3 sites Phase 3 Arrowhead Pharmaceuticals · St Louis, Missouri and 2 other locations · NCT07473843

• Inhaled ARO-RAGE for allergen-triggered mild asthma

  This trial will test whether inhaled ARO-RAGE can reduce the late asthmatic response after an allergen challenge in people with mild allergic asthma.

  Recruiting at 6 sites Phase 2 Arrowhead Pharmaceuticals · Vancouver, British Columbia and 5 other locations · NCT07241546

• ARO-DIMERPA for adults with mixed high cholesterol and triglycerides

  This trial tests whether ARO-DIMERPA, given as a single dose or repeated doses, can lower LDL cholesterol and triglycerides in adults with mixed hyperlipidemia.

  Recruiting at 19 sites Phase 1/2 Arrowhead Pharmaceuticals · Charlestown, New South Wales and 18 other locations · NCT07223658

• ARO-MAPT-SC in healthy adults and people with early Alzheimer's disease

  This trial will test whether ARO-MAPT-SC is safe, tolerable, and produces the expected drug levels and biomarker effects in healthy adults and people with early Alzheimer's disease.

  Recruiting at 4 sites Phase 1/2 Arrowhead Pharmaceuticals · East York, Ontario and 3 other locations · NCT07221344

• First-in-human ARO-ALK7 for adults with obesity, with or without type 2 diabetes

  This trial will test whether ARO-ALK7 injections are safe and can change weight and metabolic markers in adults with obesity, with or without type 2 diabetes.

  Recruiting at 7 sites Phase 1/2 Arrowhead Pharmaceuticals · Morayfield, QLC and 7 other locations · NCT06937203

• Plozasiran for adults with severe high triglycerides at risk of acute pancreatitis

  This trial will test whether plozasiran injections every three months can lower triglycerides and reduce pancreatitis risk in adults with severe high triglycerides who have had multiple recent pancreatitis attacks.

  Recruiting at 139 sites Phase 3 Arrowhead Pharmaceuticals · Los Angeles, California and 139 other locations · NCT06880770

Quick answers

How many clinical trials run by Arrowhead Pharmaceuticals are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 32 countries. The most sites are in New Zealand (4 trials), Canada (4 trials), United States (2 trials), Georgia (2 trials), Australia (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 3, Phase 3: 2, Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →